von Gunten, Stephan; Bochner, Bruce S (2009). Expression and Function of Siglec-8 in Human Eosinophils, Basophils, and Mast Cells. In: Pawankar, Ruby; Holgate, Stephen T; Rosenwasser, Lanny J (eds.) Allergy Frontiers: Classification and Pathomechanisms. Allergy Frontiers: Vol. 2 (pp. 297-313). Japan: Springer 10.1007/978-4-431-88315-9_19
Full text not available from this repository. (Request a copy)Siglec-8, the eighth member of the sialic acid-binding, immunoglobulin [Ig]-like lectin family, was initially discovered as a cell surface protein selectively expressed on human eosinophils. It is now know to also be expressed by mast cells and basophils. Siglec-8 engagement with specific antibodies causes apoptosis via caspase and mitochondrial-dependent pathways. For mast cells, inhibition of mediator release, but no apoptosis, is observed. Siglec-F is the closest mouse paralog to Siglec-8, and both selectively bind the sulfated glycan 6’-sulfo-sialyl Lewis X. Antibodies to Siglec-F reduce blood and tissue eosinophil numbers in vivo. This suggests that Siglec-8 may be a useful future therapeutic target for allergic and other eosinophilic disorders.
Item Type: |
Book Section (Book Chapter) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology |
UniBE Contributor: |
von Gunten, Stephan |
Subjects: |
600 Technology > 610 Medicine & health |
ISBN: |
978-4-431-88315-9 |
Series: |
Allergy Frontiers |
Publisher: |
Springer |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:10 |
Last Modified: |
05 Dec 2022 14:21 |
Publisher DOI: |
10.1007/978-4-431-88315-9_19 |
URI: |
https://boris.unibe.ch/id/eprint/30702 (FactScience: 194976) |
Actions (login required)
 |
Edit item |